SOLACI present at the 15 Symposium of Interventional Cardiology CardioInterv 2015

SOLACI express their gratitude to the Costantino Costantini Foundation, in Curitiba, Brazil, and to their director Dr. Costantino Costantini, for their invitation to take part in the 15 Symposium of Interventional Cardiology, CardioInterv 2015, held in Curitiba on November 26 thru 27, 2015.

The event, which took place at the Cardiology Center Costantini, proudly presented reputed international and Latin American guests and a program of outstanding scientific level. The activities included several live cases, round tables, case discussions and lectures from prestigious guests, such as doctors Andrés Íñiguez and José María de La Torre Hernández (Spain), Giulio Guagliumi and Imad Sheiban (Italy) and Jonathan M. Tobis (United States), among others.

Just like the previous year, our Society displayed a stand in the exhibition hall of the event.

More articles by this author

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

The Latin American Society of Interventional Cardiology invites you to a new virtual event hosted by the SOLACI Research Department, aimed at clarifying doubts,...

Watch our event on Evidence and Controversies of Renal Denervation in 2025

You can now watch our event, held in collaboration with Medtronic, titled "Evidence and Controversies of Renal Denervation in 2025." The event featured international experts...

March 26 – SOLACI Webinar: Evidence and Controversies in Renal Denervation in 2025

The Latin American Society of Interventional Cardiology invites you to a new virtual event supported by Medtronic. On this occasion, we will hold a 60-minute...

Uruguay Sessions 2025 | Young Interventional Cardiologists Contest

Call for Case Submission LI SOLACI Regional Sessions – 16° Southern Cone  It is with great pleasure that we hereby invite all young Latin American cardiologists...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...